Law360, New York (June 29, 2012, 9:50 PM ET) -- A New Jersey state jury on Friday handed down an $18 million verdict in favor of two users of Hoffmann-La Roche Inc.’s Accutane who allegedly developed colitis and related inflammatory bowel disorders after using the acne drug in the 1990s.
After an eight-week trial, the jury awarded $9 million each to Kathleen Rossitto and Riley Wilkinson, who had both taken Accutane and subsequently developed ulcers with colitis, an inflammatory disease of the colon, and had to eventually undergo surgeries to have their colons removed, Seeger Weiss...
Roche To Pay $18M Damages In Accutane Suit
To view the full article, take a free trial now.
